Catalyst Event
Bristol-Myers Squibb Co (BMY) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
5/12/2026, 12:00:00 AM
Bristol-Myers Squibb announced a strategic collaboration with Hengrui Pharma on May 12, 2026, to develop 13 early-stage drug programs. BMS will pay $600 million upfront with a potential total deal value of up to $15.2 billion. No market reaction yet; high impact estimated due to the massive scale of the deal ($15.2B), scheduled.
Korean Translation
2026년 5월 12일 항서제약과 13개 신약 프로그램 개발을 위한 전략적 제휴를 발표할 예정임. 아직 시장 반응이 없으나, 152억 달러 규모의 대형 계약으로 높은 시장 영향이 예상됨.
Related Recent Events
ON Semiconductor Corp (ON) · Other
Financial Analyst Day 2026 is scheduled for 2026-09-16; this event is estimated to have a ≥1% price impact, scheduled.
9/16/2026, 12:00:00 AM
Roblox Corp (RBLX) · Earnings Release
Roblox is scheduled to release its Q2 2026 earnings report on 2026-08-11. Low importance is estimated as date announcements have minimal impact, scheduled
8/11/2026, 12:00:00 AM
Kratos Defense & Security Solutions Inc (KTOS) · Earnings Release
Next quarterly earnings report for Q2 2026 is scheduled. Market impact is estimated at Medium as earnings releases typically result in 5-10% price movement.
8/6/2026, 12:00:00 AM
Curtiss-Wright Corp (CW) · Earnings Release
Q2 2026 earnings release expected.
8/5/2026, 12:00:00 AM
Occidental Petroleum Corp (OXY) · Earnings Release
Occidental Petroleum is expected to report its Q2 2026 earnings results around August 5, 2026, based on historical patterns expected.
8/5/2026, 12:00:00 AM
Masco Corporation (MAS) · Earnings Release
Masco's Q2 2026 earnings release is scheduled for July 30, 2026. Estimated 5% impact based on historical volatility during earnings periods expected.
7/30/2026, 12:00:00 AM